X

BETASERC TABLET 16mg

Product Information

Registration Status: Active

SIN11365P

BETASERC TABLET 16mg is approved to be sold in Singapore with effective from 2000-02-08. It is marketed by ABBOTT LABORATORIES (SINGAPORE ) PTE LTD, with the registration number of SIN11365P.

This product contains Betahistine 16mg in the form of TABLET. It is approved for ORAL use.

This product is manufactured by Abbott Healthcare SAS in FRANCE.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière's disease. It is also commonly used for patients with balance disorders.

Indication

For the reduction of episodes of vertigo association with Ménière's disease.

Pharmacokinetics

Absorption
When given orally, betahistine is rapidly absorbed from the gastrointestinal tract.
Distribution
Metabolism
Betahistine is metabolized primarily into 2-pyridylacetic acid and is subsequently excreted in the urine.
Elimination

Toxicity

Symptoms of overdose ( 640 mg).

Active Ingredient/Synonyms

[2-(2-Pyridyl)ethyl]methylamine | 2-(beta-Methylaminoethyl)pyridine | 2-[2-(Methylamino)ethyl]pyridine | Betahistina | Betahistinum | N-Methyl-2-(2-pyridinyl)ethanamine | N-Methyl-2-pyridineethanamine | Betahistine |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!